The proportion of individuals who truly have a specified condition that the diagnostic test classifies as positive; formally Sensitivity = TP / (TP + FN), where TP = true positives and FN = false negatives.

Principle

High sensitivity implies a low false‑negative rate for the chosen test threshold; therefore, a highly sensitive test is less likely to miss cases among those who have the condition.

Demonstration

Illustrative scenario → A screening test for Condition X is evaluated against a reference standard in a cohort known to include affected persons. Recognition → Among 100 people with Condition X, the test returns positive for 95 (TP=95, FN=5). Action → Clinicians treat negative results cautiously. Consequence → Fewer affected individuals are missed compared with a less sensitive test.

Misapplication

Interpreting sensitivity as the probability that a positive test result indicates disease (confusing Sensitivity with PPV). The semantic error is treating a conditional probability P(test+ | disease) as if it were P(disease | test+).

Consequence

Choosing a high‑sensitivity threshold reduces missed diagnoses (false negatives) but typically increases false positives at that threshold, which can lead to more confirmatory testing, follow‑up procedures, or short‑term resource use.

Reversal

When the reference standard is imperfect, spectrum bias exists, or the tested population differs from the validation sample, measured sensitivity may not generalize; in such cases high apparent sensitivity does not guarantee low false negatives in practice.

Boundary

Within: Binary diagnostic tests compared to a defined reference standard with a specified positivity threshold. Boundary case: Continuous biomarkers where sensitivity depends on chosen cut‑point. Outside: Measures of predictive accuracy conditional on prevalence (e.g., PPV), or probabilistic risk scores expressed as calibrated probabilities rather than a single positive/negative classification.

Semantic Tension

Sensitivity ↔ Specificity trade‑off: increasing sensitivity often reduces specificity for the same test, so maximizing sensitivity can conflict with minimizing false positives.

Synthesis

Sensitivity quantifies how effectively a test detects existing disease (P(test+ | disease)); its practical value depends on the clinical consequence of missed cases and on how the test threshold and population affect the false‑negative rate.